Earnings (Loss) Per Common Share |
Note 16. Earnings (Loss) Per Common Share The following table summarizes the Company’s earnings (loss) per share (USD in thousands, except per share amounts): | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | September 30, | | September 30, | | September 30, | | September 30, | | | 2020 | | 2019 | | 2020 | | 2019 | Net earnings (loss) attributable to common stockholders | | $ | (8,286) | | $ | (13,713) | | $ | (47,212) | | $ | 11,507 | Interest expense attributable to convertible promissory note | | | — | | | — | | | — | | | 125 | Net earnings (loss) assuming dilution | | $ | (8,286) | | $ | (13,713) | | $ | (47,212) | | $ | 11,632 | Basic weighted average common shares outstanding | | | 237,535,999 | | | 127,609,748 | | | 191,976,856 | | | 113,964,933 | Effect of dilutive securities | | | | | | | | | | | | | Convertible preferred shares- Series A | | | — | | | — | | | — | | | 933,333 | Conversion of restricted shares and employee stock options | | | — | | | — | | | — | | | 22,823 | Convertible promissory notes | | | — | | | — | | | — | | | 2,777,687 | Contingently issuable shares | | | — | | | — | | | — | | | 621,117 | Diluted potential common shares | | | 237,535,999 | | | 127,609,748 | | | 191,976,856 | | | 118,319,893 | Earnings (loss) per share: | | | | | | | | | | | | | Basic | | $ | (0.03) | | $ | (0.11) | | $ | (0.25) | | $ | 0.10 | Diluted | | $ | (0.03) | | $ | (0.11) | | $ | (0.25) | | $ | 0.10 |
Basic earnings (loss) per common share attributable to the Company’s shareholders is calculated by dividing the net earnings (loss) attributable to the Company’s shareholders by the weighted average number of outstanding common shares during the period. Diluted earnings (loss) per share is calculated by taking net earnings (loss) attributable to the Company’s shareholders, divided by the diluted weighted average common shares outstanding. Diluted net loss per share equals basic net loss per share because the effect of securities convertible into common shares is anti-dilutive. The following table includes the number of shares that may be dilutive potential common shares in the future. The holders of these shares do not have a contractual obligation to share in the Company’s losses and thus these shares were not included in the computation of diluted loss per share because the effect was antidilutive. (in thousands): | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | September 30, | | September 30, | | September 30, | | September 30, | | | 2020 | | 2019 | | 2020 | | 2019 | Warrants | | 1,650 | | 3,709 | | 1,650 | | 3,709 | Options and RSU | | 26,359 | | 14,971 | | 26,359 | | 14,966 | Series A Preferred Stock | | 933 | | 933 | | 933 | | — | DBOT contingent consideration | | 1,197 | | 2,323 | | 1,197 | | 2,323 | Convertible promissory note and interest | | 38,650 | | 12,418 | | 37,315 | | 9,325 | Total | | 68,789 | | 34,354 | | 67,454 | | 30,323 |
|